Yui Kudo

Yui Kudo

Auto-generated profile, based on publicly available information

Yui Kudo

Digestive Disease Center Showa University Northern Yokohama Hospital Yokohama Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
YKYui Kudo
Yui Kudo
SKShin‐Ei Kudo
Shin‐Ei Kudo
HMHideyuki Miyachi
Hideyuki Miyachi
KIKatsuro Ichimasa
Katsuro Ichimasa
YOYushi Ogawa
Yushi Ogawa
TGTakuji Gotoda
Takuji Gotoda

28 September 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
YSYuta Sato
Yuta Sato
SKShin‑Ei Kudo
Shin‑Ei Kudo
KIKatsuro Ichimasa
Katsuro Ichimasa
SMShingo Matsudaira
Shingo Matsudaira
YKYuta Kouyama
Yuta Kouyama
HMHideyuki Miyachi
Hideyuki Miyachi
With recent advances in endoscopic treatment, many T1 colorectal carcinomas (CRCs) are resected endoscopically with a negative margin. However, some lesions exhibit skip lymphovascular invasion (SLVI), which is defined as the discontinuous foci of the tumor cells within the colon wall. The aim of the present study was to reveal the clinicopathological features of T1 CRCs with SLVI and validate the Japanese guidelines regarding SLVI. A total of 741 patients with T1 CRCs that were resected surgically between April 2001 and October 2016 in our hospital were divided into two groups: With SLVI and without SLVI. Clinicopathological features compared between the two groups were patient's gender, age, tumor size, location, morphology, lymphovascular invasion, tumor differentiation, tumor budding and lymph node metastasis. The incidence of T1 CRCs with SLVI was 0.9% (7/741). All cases with SLVI were found in the sigmoid colon or rectum. T1 CRCs with SLVI showed significantly higher rates of lymphovascular invasion than those without SLVI (P<0.01). In conclusion, lymphovascular invasion was a significant risk factor for SLVI in T1 CRCs, and for which surgical colectomy was necessary. The Japanese guidelines are appropriate regarding SLVI. Registered in the University Hospital Medical Network Clinical Trials Registry (UMIN000027097).